Efficacy of Abiraterone and Enzalutamide in Pre- and Postdocetaxel Castration-Resistant Prostate Cancer: A Trial-Level Meta-Analysis

We examined the comparative efficacies of first-line abiraterone and enzalutamide in pre- and postdocetaxel settings in castration-resistant prostate cancer (CRPC) through a trial level meta-analysis. A mixed method approach was applied to 19 unique studies containing 17 median overall survival (OS)...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Prostate Cancer
Main Authors: Fang, Mike, Nakazawa, Mary, Antonarakis, Emmanuel S., Li, Chun
Formato: Artigo
Idioma:Inglês
Publicado: Hindawi 2017
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5735648/
https://ncbi.nlm.nih.gov/pubmed/29359049
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/8560827
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares